Why Cannabis Companies Traded Higher; Here’s 60 Biggest Movers From Yesterday
Today, 3:58 PM
Gainers
Enveric Biosciences Announces 1-For-50 Reverse Stock Split
Today, 3:58 PM
Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
Today, 3:58 PM
Article by Jason Najum.
Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the industry to mature.
Enveric Biosciences Advances Drug Development For Mental Health Indications And Intellectual Property Portfolio
Today, 3:58 PM
-- Advancing to IND-enabling studies with multiple drug candidates --
-- Enveric’s Growing Patent Portfolio Validated --
Why These Casino Stocks Are Moving Lower, Here’s 45 Stocks Moving In Monday’s Mid-Day Session
Today, 3:58 PM
Gainers
Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
10 Psychedelics CEOs To Pay Attention To In 2022
Today, 3:58 PM
By Javier Hasse and Aaron Bry.
2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.